Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 401–500 of 1,002
He, S., Li, X., Mittra, N., Bhattacharjee, A., Wang, H., Song, S., Zhao, S., Liu, F., & Han, X. (2025) · Advanced Science · doi:10.1002/advs.202410910 · Cited by 34
Guest, F. L., Rahmoune, H., & Guest, P. C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-42667-5_8 · Cited by 34
Shakaib, B., Zohra, T., Ikram, A., Shakaib, M. B., Ali, A. A. A., Bashir, A., Salman, M., Khan, M. A., & Ansari, J. A. (2021) · Virology Journal · doi:10.1186/s12985-021-01578-0 · Cited by 39
“Moreover, NLRP3 inflammasomemediated inflammation has been linked to accumulation of neurodegeneration-associated peptides–such as fibrillar amyloid-β [44], which may aggravate neurodegeneration and progression of Alzheimer’s disease [40, 45, 46].”
BackgroundThe menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases
Elkins, M., Jain, N., & Tükel, Ç. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102473 · Cited by 35
Shi, R., Liang, R., Wang, F., Wang, L., Zidai, W., Zhang, J., Min, L., Du, X., Sun, S., Xiao, C., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01961-6 · Cited by 35
“The inflammasome adaptor protein PYCARD (known as ASC) is a potential pyroptosis biomarker engaged in inflammation and related to immune response[40], which provides a new insight for the pathogenesis of inflammatory diseases[41, 42].”
Ko, Y. J., Lee, J., Yang, E.-J., Jang, N., Park, J., Jeon, Y. K., Yu, J., Cho, N., Kim, H.-S., & Kwon, I. C. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119543 · Cited by 36
Severini, C., Barbato, C., Certo, M. G. D., Gabanella, F., Petrella, C., Stadio, A. D., VINCENTIIS, M. D., Polimeni, A., Ralli, M., & Greco, A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200621204546 · Cited by 35
“Moreover, in transgenic APPSwePSEN1dE9 mice, intrahippocampal injection of prion-like ASC specks, produced by microglia in response to NLRP3 activation, significantly increased Aβ pathology, while co-application of an anti-ASC antibody reduced Aβ deposit and improved cognitive functions [83].”
BackgroundInflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
Lee, S. Y., Yates, N., & Tye, S. (2021) · The Neuroscientist · doi:10.1177/1073858421992265 · Cited by 30
Yang, T., Zhang, L., Shang, Y., Zhu, Z., Jin, S., Guo, Z., & Wang, X. (2022) · Chemical Science · doi:10.1039/d1sc06071f · Cited by 36
Infection and inflammation: New perspectives on Alzheimer's disease
Whitson, H. E., Colton, C. A., Khoury, J. B. E., Gate, D., Goate, A., Heneka, M. T., Kaddurah‐Daouk, R., Klein, R. S., Shinohara, M. L., Sisodia, S. S., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100462 · Cited by 37
Self-citationLiu, Y., Tan, Y., Zhang, Z., Li, H., Yi, M., Zhang, Z., Hui, S., & Peng, W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101831 · Cited by 37
Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease
Shippy, D. C., Evered, A. H., & Ulland, T. K. (2024) · Immunological Reviews · doi:10.1111/imr.13365 · Cited by 36
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I. A., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 35
Xu, Z., Shabestari, S. K., Barannikov, S., Bieniek, K. F., Blurton-Jones, M. M., Palavicini, J. P., & Han, X. (2025) · Nature Communications · doi:10.1038/s41467-025-64161-z · Cited by 39
“While microglial lipid handling intersects critically with A β pathology 20 , chronic activation paradoxically impairs phagocytosis 21 .”
Xue-ju, Z., Liu, W., Cao, Y. W., & Tan, W. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00255 · Cited by 39
D’Antongiovanni, V., Pellegrini, C., Antonioli, L., Benvenuti, L., Salvo, C. D., Flori, L., Piccarducci, R., Daniele, S., Martelli, A., Calderone, V., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.748021 · Cited by 33
Xie, Z., Meng, J., Kong, W., Wu, Z., Lan, F., Narengaowa, Hayashi, Y., Yang, Q., Bai, Z., Nakanishi, H., et al. (2022) · Aging Cell · doi:10.1111/acel.13565 · Cited by 36
“Genetic and epigenetic studies, transcriptome analysis of brains of patients with AD, and quantitative analysis of traits expressed in monocytes all support a role for the innate immune system in AD (Venegas et al., 2017).”
BackgroundBased on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
Yang, H., Li, J., Li, X., Ma, L., Hou, M., Zhou, H., & Zhou, R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.927530 · Cited by 34
Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome
Shu, X., Chen, W., Tu, W.-Y., Zhong, K., Qi, S., Wang, A., Bai, L., Zhang, S.-X., Luo, B., Xu, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112133 · Cited by 33
Takeda, K., Uda, A., Mitsubori, M., Nagashima, S., Iwasaki, H., Ito, N., Shiiba, I., Ishido, S., Matsuoka, M., Inatome, R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01720-2 · Cited by 32
Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
Fülöp, T., Munawara, U., Larbi, A., Desroches, M., Rodrigues, S., Catanzaro, M., Guidolin, A., Khalil, A., Bernier, F., Barron, A. E., et al. (2020) · CNS Drugs · doi:10.1007/s40263-020-00737-1 · Cited by 36
Xue, F., Tian, J., Yu, C., Du, H., & Guo, L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105272 · Cited by 32
Wang, X., Gao, F., Xu, W., Cao, Y., Wang, J., & Zhu, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1020614 · Cited by 35
Forrest, O. A., Dobosh, B., Ingersoll, S. A., Rao, S., Rojas, A., Laval, J., Alvarez, J. A., Brown, M. R., Tangpricha, V., & Tirouvanziam, R. M. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab0321-149r · Cited by 33
A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism
Matsuzaki, K., Nakajima, A., Guo, Y., & Ohizumi, Y. (2022) · Nutrients · doi:10.3390/nu14091847 · Cited by 33
Liu, X., Cheng, Z.-Y., Li, Y.-F., Liu, C., Wang, C., Gong, X., & He, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175443 · Cited by 34
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
Thapa, P., Upadhyay, S. P., Singh, V., Boinpelly, V. C., Zhou, J., Johnson, D. K., Gurung, P., Lee, E. S., Sharma, R., & Sharma, M. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100100 · Cited by 38
Lin, W., Zhao, L., Liang, G., Zhou, R., Zheng, X., Tao, R., Huo, Q., Su, C.-F., Li, M., Xu, N., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02698-w · Cited by 33
Pyroptosis in neurodegenerative diseases: from bench to bedside
Wu, K., Wang, W.-R., Cheng, Q.-H., Li, H., Yan, W.-Z., Zhou, F.-R., & Zhang, R. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-023-09820-x · Cited by 33
Rusty Microglia: Trainers of Innate Immunity in Alzheimer's Disease
Sfera, A., Gradini, R., Cummings, M., Diaz, E. L., Price, A. I., & Osorio, C. P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01062 · Cited by 35
“Suppressing NLRP3 by ASC inhibition is an attractive AD strategy as ASC was recently found to disseminate β amyloid throughout the CNS (66, 172).”
BackgroundAuger, A., Faidi, R., Rickman, A. D., Peña-Martinez, C., Fajfer, A., Carling, J., Hilyard, A., Ali, M., Ono, R., Cleveland, C., et al. (2025) · npj Dementia · doi:10.1038/s44400-025-00011-5 · Cited by 32
Uncovering plaque-glia niches in human Alzheimer’s disease brains using spatial transcriptomics
Avey, D. R., Ng, B., Vialle, R. A., Kearns, N. A., Lopes, K. D. P., Iatrou, A., Tissera, S. L. D., Vyas, H., Saunders, D. M., Flood, D. J., et al. (2025) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00002-z · Cited by 39
“Second, microglia activate the NLRP3 inflammasome, which subsequently drives the formation and release of ASC specks (apop-tosis-associated speck-like protein containing a CARD), increasing Aβ oligomer formation, immune response, and neuronal damage [65].”
Caspases orchestrate microglia instrumental functions
Shen, X., Venero, J. L., Joseph, B., & Burguillos, M. Á. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.007 · Cited by 32
Neuro-regeneration Therapeutic for Alzheimer’s Dementia: Perspectives on Neurotrophic Activity
Sun, M., & Alkon, D. L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.008 · Cited by 31
Proteomic Approaches to Study Cysteine Oxidation: Applications in Neurodegenerative Diseases
Pham, T. K., Buczek, W. A., Mead, R. J., Shaw, P. J., & Collins, M. O. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.678837 · Cited by 35
Liu, J., Jiao, L., Zhong, X., Yao, W., Du, K., Lu, S., Wu, Y., Ma, T., Tong, J., Xu, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.856628 · Cited by 33
Hassan, H., Rawlinson, C., Lan, Y., Jenkins, S. I., & Chen, R. (2025) · Biomolecules · doi:10.3390/biom15111629 · Cited by 34
“Furthermore, inflammasome-derived ASC (Apoptosis-associated Speck-like protein containing a CARD) specks released by degenerating microglia can bind to A β oligomers and promote plaque formation, thereby impairing microglial clearance mechanisms [85].”
The Viral Hypothesis in Alzheimer’s Disease: Novel Insights and Pathogen-Based Biomarkers
Naughton, S. X., Raval, U., & Pasinetti, G. M. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030074 · Cited by 30
“gingivalis induces neuroinflammation, inflammasome activation, and other immune system multiprotein complexes in the brain that result in neurodegeneration and Aβ plaque formation [27,28].”
BackgroundDiscovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes
Sebastian-Valverde, M., Wu, H. D., Rahim, M. A., Sánchez, R., Kumar, K., Vita, R. J. D., & Pasinetti, G. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100597 · Cited by 32
Yang, Y., Seok, M., Kim, Y. E., Choi, Y., Song, J., Sulistio, Y. A., Kim, S., Chang, M., Oh, S., Nam, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01693-6 · Cited by 32
“7I), collectively indicating that A β - and/or TAU pathology-induced neuronal and synaptic losses were alleviated by glia-speci fi c Nurr1 + Foxa2 expression.”
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Ghiasi, S. M., Dahllöf, M. S., Osmai, Y., Osmai, M., Jakobsen, K. K., Aivazidis, A., Tyrberg, B., Perruzza, L., Prause, M. C. B., Christensen, D. P., et al. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.08.001 · Cited by 32
Cellular Biology of Tau Diversity and Pathogenic Conformers
Kang, S., Eskandari‐Sedighi, G., Hromádková, L., Safar, J., & Westaway, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590199 · Cited by 30
The Impact of Ageing on the CNS Immune Response in Alzheimer’s Disease
Chee, S. E. J., & Solito, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738511 · Cited by 30
Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease
Ramos, A., Joshi, R., & Szabó, G. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.910298 · Cited by 31
“Furthermore, different studies have demonstrated that Aβ or tau aggregates activate the NLRP3 inflammasome, causing the subsequent release of IL-1β, Caspase-1 and ASC specs that perpetuate the aggregation of Aβ via a positive feedback loop (Venegas et al., 2017; Luciunaite et al., 2020).”
BackgroundEvidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
Kabir, M. T., Uddin, M. S., Abdeen, A., Ashraf, G. M., Perveen, A., Hafeez, A., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200618114924 · Cited by 29
Ge, T.-Q., Guan, P.-P., & Wang, P. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105868 · Cited by 29
Takatori, S., Kondo, M., & Tomita, T. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00383-4 · Cited by 29
Tang, H., & Harte, M. (2021) · Genes · doi:10.3390/genes12111753 · Cited by 28
Advances in the Functions of Thioredoxin System in Central Nervous System Diseases
Jia, J., Xu, G., Zhu, D., Liu, H., Zeng, X., & Li, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0079 · Cited by 33
“The NLRP3 in-flammasome activation was associated with seeding and spreading of A b pathology in patients with AD (Venegas et al, 2017).”
Vaccari, J. P. D. R., Mim, C., Hadad, R., Cyr, B. S., Stefansdottir, T. A., & Keane, R. W. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.016 · Cited by 30
“In AD pathology, ASC specks cross-seed with amyloid beta (Aβ1−42), in the extracellular space, which boosts Aβ1−42 toxicity in microglia.(46,47) Experiments in animal models of tau(34,48,49) and α-synuclein pathology(50) show that transfer of anti-tau or anti-α-synuclein antibodies induce reduced levels of assembled p…”
BackgroundYan, Y., Pu, J., Zheng, R., Fang, Y., Gu, L., Guo, T., Si, X., Zhou, C., Chen, Y., Liu, Y., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15537 · Cited by 30
“ASC specks can bind to βamyloid and promote oligomer formation, and clustering of βamyloid around ACS also exacerbates the inflammatory response [19, 20].”
BackgroundKattan, D., Barsa, C., Mekhijian, S., Shakkour, Z., Jammoul, M., Doumit, M., Zabala, M. C. P., Darwiche, N., Eid, A. H., Mechref, Y. S., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104969 · Cited by 28
FAM69C functions as a kinase for eIF2α and promotes stress granule assembly
Wu, Z., Mei, F., Gan, Y., Liu, A., Hu, J., Jin, Y., & Yin, Y. (2023) · EMBO Reports · doi:10.15252/embr.202255641 · Cited by 28
“Moreover, previous studies implicated that NLRP3 inflammasomes are essential for the development and progression of amyloid-b (A b ) pathology and tau pathology in mouse models (Venegas et al , 2017; Ising et al , 2019).”
Muscimol inhibits plasma membrane rupture and ninjurin-1(NINJ1) oligomerization during pyroptosis
den Hartigh, A. B., Loomis, W. P., Anderson, M. J., Frølund, B., & Fink, S. L. (2023) · Communications Biology · doi:10.1038/s42003-023-05354-4 · Cited by 30
Bowen, C. A., Childers, G. M., Perry, C. E., Martin, N. P., McPherson, C. A., Lauten, T. H., Santos, J. H., & Harry, G. J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126919 · Cited by 28
Tian, L., Long, G., Zhu, S., Wang, Y., Xu, P., Liu, L., Yao, H., Fang, S., Chen, S., & Li, S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2427257122 · Cited by 27
“This aligns with recent findings showing that inflammatory vesicle - associated apoptotic speck - like protein in microglia facilitates A β accumu lation, while microglial depletion reduces plaque compaction and exacerbates neurotic dystrophy ( 24 – 26 ).”
Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 30
“…activation of microglia releases adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) that assembles into ASC specks, which can sustain an ongoing immune response and directly induce Aβ seeding and spreading of the pathology (Venegas et al. 2017; Bettcher et al. 2021).”
Faridar, A., Gamez, N., Li, D., Wang, Y., Boradia, R., Thome, A. D., Zhao, W., Beers, D. R., Thonhoff, J. R., Nakawah, M. O., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01791-x · Cited by 33
An association between mitochondria and microglia effector function: what do we think we know?
Harry, G. J., Childers, G. M., Giridharan, S., & Hernandes, I. L. (2020) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.07 · Cited by 29
“In addition to the release of inflammatory factors, the physical release of ASC specks into the extracellular environment represents a stimulus for activating phagocytic cells in the immediate environment, thus contributing to a prolonged propagation of inflammation([192]) or other biological responses([193]).”
BackgroundAnticoagulants for Treatment of Alzheimer’s Disease
Grossmann, K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200610 · Cited by 29
“In particular, inflammatory processes, emanating from activated microglia cells and their release of interleukins and ASC (apoptosisassociated speck-like protein containing a CARD) protein complexes in microgliosis, promote the formation and spread of cerebral A deposits [27, 28].”
BackgroundCao, C., Yang, Y.-X., Xie, Z., Chen, X., Shi, X., Yin, X., & Gao, J. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105854 · Cited by 27
ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux
Martín‐Sánchez, F., Compan, V., Peñín‐Franch, A., Tapia‐Abellán, A., Gómez, A. I., Baños-Gregori, M. C., Schmidt, F. I., & Pelegrín, P. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202003053 · Cited by 27
“In any case, modulating the structure of the ASC oligomer could be useful in treating different pathologies such as Alzheimer’s disease, where the ASC oligomer is central to the development of the disease (Venegas et al., 2017).”
BackgroundImmunity impacts cognitive deficits across neurological disorders
Shaw, B. C., Anders, V., Tinkey, R. A., Habean, M. L., Brock, O. D., Frostino, B. J., & Williams, J. L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15999 · Cited by 44
“Importantly, they show that ASC also cosediments with A β from human AD brain and that ASC increases the rate at which A β oligomerizes in a cell-free aggregation assay (Venegas et al., 2017).”
InfluentialRisen, S. J., Boland, S. W., Sharma, S., Weisman, G. M., Shirley, P. M., Latham, A. S., Hay, A. J. D., Gilberto, V. S., Hines, A. D., Brindley, S. M., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00846 · Cited by 28
Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC
Sušjan, P., Lainšček, D., Strmšek, Ž., Hodnik, V., Anderluh, G., & Hafner‐Bratkovič, I. (2020) · The FASEB Journal · doi:10.1096/fj.201902938rr · Cited by 28
Immune-Related Hub Genes and the Competitive Endogenous RNA Network in Alzheimer’s Disease
Xu, H., & Jia, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200081 · Cited by 27
“Activated microglia release an apoptosis-associated speck-like protein containing a CARD (ASC) protein, which acts as an inflammation-driven cross-seed for the amyloid-(cid:2) pathology [16].”
Liu, Y., Subedi, K., Baride, A., Romanova, S., Callegari, E. A., Huber, C. C., Wang, X., & Wang, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02081-7 · Cited by 28
Yang, Y., Zhang, J., Yang, C., Dong, B., Fu, Y., Wang, Y., Gong, M., Liu, T., Qiu, P., Xie, W., et al. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148206 · Cited by 28
Lv, L., Maimaitiming, M., Huang, Y., Yang, J., Chen, S., Sun, Y., Zhang, X., Li, X., Xue, C., Wang, P., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115346 · Cited by 27
Ye, X., Zhang, H., Li, Q., Ren, H., Xu, X., & Li, X.-R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108625 · Cited by 28
“At the same time, pathological innate immune activation and subsequent production of inflammatory mediators, such as NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3), ASC (apoptosisassociated speck-like protein), and caspase-1, promote the progress of AD and provide an effective therapeutic target for treating…”
BackgroundInfluentialRecent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease
Su, M., Nizamutdinov, D., Liu, H., & Huang, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119272 · Cited by 28
“When the ASC domain of this inflammasome is secreted by microglia exocytosis, it can serve as a core for further Aβ accumulation [121].”
BackgroundIs Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Swanton, T., Cook, J., Beswick, J. A., Freeman, S., Lawrence, C. B., & Brough, D. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218786210 · Cited by 29
Sex-specific effects of central adiposity and inflammatory markers on limbic microstructure
Metzler‐Baddeley, C., Mole, J. P., Leonavičiūtė, E., Sims, R., Kidd, E. J., Ertefai, B., Kelso-Mitchell, A., Gidney, F., Fasano, F., Evans, J., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.007 · Cited by 27
“, 2015; Sarlus and Heneka, 2017; Tejera and Heneka, 2016), and it has therefore been proposed that obesity induced gut dysbiosis may trigger microglia mediated neuroinflammation, and that this in turn may contribute to disease development (Sochocka et al., 2018; Venegas et al., 2017), potentially many years prior to t…”
BackgroundMicroglia in Alzheimer’s Disease
Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 28
The Potential Roles of Redox Enzymes in Alzheimer’s Disease: Focus on Thioredoxin
Jia, J., Zeng, X., Xu, G., & Wang, Z. (2021) · ASN NEURO · doi:10.1177/1759091421994351 · Cited by 29
Kobe, B., Nanson, J. D., Hoad, M., Blumenthal, A., Gambin, Y., Sierecki, E., Stacey, K. J., Ve, T., & Halfmann, R. (2025) · Biochemical Journal · doi:10.1042/bcj20220094 · Cited by 25
“The physiological implications for extracellular signalosomes are incompletely understood but may reach beyond their initial signalling functions, e.g. as seeds for pathological protein aggregation [64].”
Polymorphism of Amyloid Fibrils Induced by Catalytic Seeding: A Vibrational Circular Dichroism Study
Krupová, M., Kessler, J., & Bouř, P. (2020) · ChemPhysChem · doi:10.1002/cphc.202000797 · Cited by 25
Yang, G., Zhu, T., Wang, D., Liu, Z., Zhang, R., Han, G., Tian, X., Liu, B., Han, M., & Zhang, Z. (2021) · Chemical Communications · doi:10.1039/d1cc02008k · Cited by 25
Arf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes
Lee, S., Ishitsuka, A., Kuroki, T., Lin, Y.-H., Shibuya, A., Hongu, T., Funakoshi, Y., Kanaho, Y., Nagata, K., & Kawaguchi, A. (2021) · JCI Insight · doi:10.1172/jci.insight.139190 · Cited by 25
“Furthermore, extracellular ASC specks are also causative agents of other inflammatory diseases, including chronic obstructive pulmonary disease (15), chronic infantile neurological cutaneous and articular syndrome (16), and Alzheimer’s disease (39).”
InfluentialWang, Y., Zhu, J., Jia, W., Xiong, H., Qiu, W., Xu, R., & Lin, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c14626 · Cited by 25
Budvytytė, R., & Valinčius, G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220434 · Cited by 25
Uncovering Plaque-Glia Niches in Human Alzheimer’s Disease Brains Using Spatial Transcriptomics
Avey, D. R., Ng, B., Vialle, R. A., Kearns, N. A., de Paiva Lopes, K., Iatrou, A., De Tissera, S., Vyas, H., Saunders, D. M., Flood, D. J., et al. (2024) · doi:10.1101/2024.09.05.611566 · Cited by 24
“Second, microglia activate the NLRP3 inflammasome, which subsequently drives the formation and release of ASC specks (apoptosis-associated speck-like protein containing a CARD), increasing Aβ oligomer formation, immune response, and neuronal damage 55 .”
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 26
Grossmann, K. (2022) · Biomedicines · doi:10.3390/biomedicines10081890 · Cited by 26
“Among these proteins, small cytokine peptides and inflammasome-derived protein complexes are able to stimulate the production, deposition, and spreading of Aß in the brain [54].”
BackgroundJayashankar, S. S., Arifin, K. T., & Nasaruddin, M. L. (2023) · Nutrients · doi:10.3390/nu15030524 · Cited by 26
“In contrast, the homogenates from the brains of the AD mouse model failed to exert the same observation in ASC-deficient AD mice [55].”
BackgroundResultPan, J., Peng, J., Li, X., Wang, H., Rong, X., & Peng, Y. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03232-y · Cited by 35
“1 3 amyloid-β pathogenic process in Alzheimer’s disease [42].”
BackgroundIs Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
Sbai, O., Bazzani, V., Tapaswi, S., McHale, J., Vascotto, C., & Perrone, L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1166879 · Cited by 26
“In early phase AD patients, the levels of IL-1β and caspase 1 activity are enhanced, confirming the over activation of NLRP3 as early event in AD (Venegas et al., 2017).”
BackgroundDaily, K. P., Badr, A., Eltobgy, M. M., Estfanous, S. Z. K., Whitham, O. D., Tan, M. H., Carafice, C., Krause, K., McNamara, A. J., Hamilton, K., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01390-2 · Cited by 27
“Additionally, the release of apop-tosis-associated speck-like protein containing a CARD (ASC) as a by-product of inflammasome activation serves as a seeding point for the formation of Aβ plaques [71].”
BackgroundCheon, S. Y., Kim, J., Kim, S. Y., Kim, E. J., & Koo, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031103 · Cited by 24
“In contrast, genetic ASC deficiency in APPswe/PSEN1dE9 mice shows a beneficial role in the pathology of AD [111].”
BackgroundMerighi, S., Nigro, M., Travagli, A., Pasquini, S., Borea, P. A., Varani, K., Vincenzi, F., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095056 · Cited by 26
The Role of Aldose Reductase in Beta-Amyloid-Induced Microglia Activation
Huang, Y.-K., Liu, C.-C., Wang, S., Cheng, H.-C., Meadows, C., & Chang, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315088 · Cited by 24
“In the condition of β‐amyloid accumulation, surrounding microglia become activated and play a critical role in inflammation and its subsequent pathogenesis [6].”
BackgroundInfluentialZhang, N., Nao, J., & Dong, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06672 · Cited by 25
Li, K., Shi, G., Zhao, Y., Chen, Y., Gao, J., Yao, L., Zhao, J., Li, H., Xu, Y., & Chen, Y. (2021) · Neural Plasticity · doi:10.1155/2021/8814616 · Cited by 27
“Recent studies provide evidence that the NLRP3 inflammasome are essential for both the progression of Aβ and tau pathology directly in AD [12, 13].”
BackgroundResultDorion, M., Casas, D., Shlaifer, I., Yaqubi, M., Fleming, P., Karpilovsky, N. C., Chen, C. X. ‐., Nicouleau, M., Piscopo, V. E. C., MacDougall, E. J., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00723-x · Cited by 23
Fixemer, S., de la Maza, M. M., Hammer, G. P., Jeannelle, F., Schreiner, S., Gérardy, J., Boluda, S., Mirault, D., Mechawar, N., Mittelbronn, M. G. A., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02857-8 · Cited by 26
“PaM are associated with Aβ core plaque clearance [30] and formation [32, 86, 98], with lipid metabolism [31, 83] and local neuroinflammation [34, 47, 101].”
Chen, P., Bai, Q., Wu, Y., Zeng, Q., Song, X., Guo, Y., Zhou, P., Wang, Y., Liao, X., Wang, Q.-L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.712907 · Cited by 32
Arroyo‐García, L. E., Bachiller, S., Ruiz, R., Boza‐Serrano, A., Moreno, A. R., Deierborg, T., Andrade‐Talavera, Y., & Fisahn, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00338-0 · Cited by 22
“Recently, direct involvement of microglia-released gal3 and Aβ cross-seeding agents in plaque formation has been validated [27, 115, 116].”
BackgroundMitophagy and long-term neuronal homeostasis
Markaki, M., Tsagkari, D., & Tavernarakis, N. (2023) · Journal of Cell Science · doi:10.1242/jcs.260638 · Cited by 23
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 25
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.